Lead poisoning in children

C M Berlin1

  • 1Department of Pediatrics, Milton S. Hershey Medical Center, Pannsylvania State University College of Medicine, Harshey 17033-0850, USA.

Insights

Pediatric lead exposure is a persistent issue. Meso 2,3-dimercaptosuccinic acid (DMSA) shows promise for lowering blood lead levels in children, though environmental cleanup remains crucial.

Area of Science:

  • Environmental Health
  • Pediatric Toxicology
  • Public Health

Background:

  • Childhood lead exposure and body burden remain significant public health concerns in the U.S.
  • Widespread blood lead screening identifies many at-risk children, but screening criteria and age targets are debated.
  • Lead screening has been less effective in certain populations, including rural areas and HMOs.

Purpose of the Study:

  • To evaluate the effectiveness of meso 2,3-dimercaptosuccinic acid (DMSA) for treating lead exposure in children.
  • To assess the efficacy of DMSA in lowering blood lead concentrations within specific ranges.
  • To highlight the ongoing importance of environmental lead reduction strategies.

Main Methods:

  • Review of evidence on DMSA efficacy for lead chelation in children.
  • Analysis of blood lead concentration data in relation to DMSA treatment.
  • Consideration of current treatment guidelines and limitations.

Main Results:

  • DMSA is approved for oral chelation in children with blood lead levels above 45 µg/dL.
  • Evidence suggests DMSA effectively lowers blood lead levels in children with concentrations between 25 and 45 µg/dL.
  • The long-term effectiveness of chelation at lower lead levels requires further investigation.

Conclusions:

  • Meso 2,3-dimercaptosuccinic acid (DMSA) offers a treatment option for children with elevated lead levels.
  • Environmental decontamination remains the primary and most critical intervention for preventing and treating childhood lead exposure.
  • Further research is needed to determine the long-term benefits of DMSA chelation at lower blood lead concentrations.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...